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The multiplication of certain viruses is thought to occur as a series of step- 
wise events (1).  The identifiable steps in a  single cycle of multiplication are: 
(1)  adsorption of viral particles to susceptible host cells;  (2)  a  latent period 
during which there is no demonstrable increase in the amount of virus;  (3) 
release of newly formed viral particles from infected cells.  Such cycles are re- 
peated in series until a lack of susceptible ceils or some other factors limit the 
process. Most workers accept the concept that formation of new viral particles 
occurs  during  the  latent period,  probably within,  although possibly at  the 
surface of, susceptible cells. That viral multiplication occurs in discrete cycles 
first was shown cleariy wi~h bacterial viruses of the T series of coliphage (1, 2). 
A similar course of events appears to prevail with influenza viruses (3, 4); the 
time intervals in this case are much longer and are measured in hours rather 
than  in minutes, as with bacteriophages.  With mumps virus  (5)  the  latent 
period is still longer, i.e.,  of the order of 24  hours, and a  complete cycle of 
multiplication requires about 32 hours. 
In  the preceding paper  (6)  it was  shown  that  the  rate  of multiplication 
of pneumonia virus of mice (PVM) is relatively constant and that the amount 
of pneumonia which develops is related to, and predictable from, the quantity 
of virus formed at a given time. Although neither the rate of extension of the 
pneumonic lesion nor the rate of increase in viral concentration appears to be 
affected by wide variations in the amount of virus inoculated, both the extent 
of viral multiplication and the amount of pneumonia induced are affected by 
the size of the inoculum. These findings led to the hypothesis that PVM, like 
certain other viruses, multiplies in discrete cycles in susceptible  cells  of the 
mouse lung. 
The present paper is concerned with an experimental test of this postulate. 
The evidence obtained indicates that, after intranasal inoculation with PVM, 
a large proportion of the infective virus disappears; a prolonged latent period 
then occurs and is followed by a  progressive  increase in viral concentration 
in the lung. These findings appear to be consistent with the hypothesis stated 
above. 
151 152  CHARACTERISTICS OF  THE  MULTIPLICATION  CYCLE O~"  PVM 
Materials and Methods 
Virus.--Pneumonia  virus of mice (PVM),  strain  15  (7),  was employed. The agent was 
maintained by occasional passage in the mouse lung (8), and stored as a  10 per cent mouse 
lung suspension  in a solid CO, cabinet. 
Mice.--Albino  Swiss mice of the Rockefeller Institute strain were employed in most ex- 
periments. In certain experiments mice of a similar strain obtained from a commercial breeder 
were used.win all cases 6 mice, 3 to 4 weeks of age, were used in each group. 
ttemagglutination Titratlons.--To  measure small quantities of PVM by the in vitro t~h- 
nique, a  modification was made in the method previously described  (9).  Lung suspensions 
were prepared in 15 per cent concentration in distilled water (10) and were finely ground to 
break up cells. The usual heating at 70°C. for 30 minutes was followed  by centrifugation at 
7,750  g for  10  minutes.  Sodium chloride was added  to each supernate  to give an  isotonic 
solution. Titratiuns were carried out with serial twofold dilutions in 0.4 cc. volumes. To each 
tube was added an equal volume of 0.I per cent mouse RBC suspension  containing heated and 
filtered  normal  horse  serum  (9).  The pattern  of erythrocytes at the bottom  of each tube 
Was recorded after 4 hours at room temperature, and the end point was taken as the highest 
dilution at which the RBC were clumped on the walls of the tube (3+). Although considerably 
higher  titers,  usually  16-fold,  are  obtained  when lung suspensions  are prepared in distilled 
water and a final concentration of 0.05 per cent RBC is used, it should be emphasized that the 
relation between the titer of PVM and  RBC concentration is not linear, as with influenza 
viruses  (11).  Titrations were carried out in duplicate, and  the end point was taken as the 
reciprocal of the mean of the final dilutions of the suspension. 
Infectivity  TiCrations.--Titrations were carried out as previously described  (8), Lung sus- 
pensions prepared  as  above were centrifuged at  1500 g.p.x(,  for 3  minutes.  Serial tenfold 
dilutions of each supernate were made in sterile 10 per cent normal horse serum broth, and 
0.05  cc.  of each dilution was inoculated intranasally  into each of 6  mice. The end points 
(M.S.50)  were calculated as previously described (8)  and are expressed  in terms of the final 
dilution of the ground  lung. Thus,  infectivity titers are tenfold higher than  corresponding 
hemagglutination titers. 
EXPERIMENTAL 
When  relatively  long  intervals,  i.e.,  2  days,  are  employed,  as  in  the  pre- 
ceding study  (5), to determine the rate of increase of PVM  in the mouse lung, 
the rate appears to be linear and changes which occur within the first 48 hours 
are  not  revealed.  However,  the  initial period  of  infection with  PVM  can  be 
adequately  studied  if a  large  number  of  susceptible  cells are  infected  at  one 
time by  the  inoculation  of as  large  a  quantity  of PVM  as  is practicable  in  a 
single dose.  The viral concentration  of the mouse lung  is then  determined  at 
short  intervals by a  modified hemagglutination  technique  devised to measure 
small quantities  of virus. 
Each of a  large number of mice was inoculated intranasally with 10  a'6 M.S.50 doses of 
PVM. Beginning 5 minutes after inoculation and  thereafter at short intervals, groups of 5 
mice were killed and the lungs of each group were pooled and stored at -  28°C. until the com- 
pletion of the experiment. Lung suspensions  were prepared and hemagglutination titrations 
were carried out in duplicate as described above. It should be emphasized that, because of the 
procedure  employed,  the  hemagglutination  titers  are  16-fold  higher  for  equivalent  viral 
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The results of two typical experiments are summarized in Fig.  1. The titer 
indicated at zero time is the theoretical value computed from the quantity of 
virus  inoculated.  Beginning  within  a  few  minutes  and  continuing  through 
the  first  15  hours  after inoculation,  there  was a  progressive decrease  in  the 
concentration of virus demonstrable by the hemagglutination technique.  Fol- 
lowing this decremental period, a plateau occurred and was maintained for an 
interval  of  about  3  hours.  Mter  this  "latent  period"  of  approximately  18 
hours' duration,  there was a progressive increase in viral concentration which 
occurred during a  further period of 10 to 14 hours.  Between 28 and 36 hours 
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FiG. l.  Single cycles of multiplication of PVM in the mouse lung, as revealed by in ~ilvo 
measurement of viral concentration. The experimental points represent the geometric mean 
values of hemagglutination titration  end points in two experiments. In each experiment a 
group of 6 mice inoculated with l0  a.5 M.S.50 doses of virus,was used at each time interval. 
The titer shown at zero time was computed from the titer of the inoculum. 
tion.  At 48 hours,  however, a  second marked increase in viral concentration 
had occurred. 
On  the  basis of these results it appears that,  with PVM, a  single cycle of 
multiplication 'occurs in 28 to 30 hours and that the quantity of virus present 
in the lung at completion of the first cycle is almost identical with the amount 
present  a  few minutes  after  inoculation.  The  16-fold  or greater  increase  in 
viral  concentration  between  18  and  30  hours  after  inoculation  corresponds 
almost  precisely  to  the  extent  of  the  decrease  in  concentration  between  6 
minutes and 15 hours. Not until 48 hours did the concentration definitely ex- 
ceed  that  at  6  minutes.  This  surprising  result  merited  additional  investiga- 
tion. 
Features of a Single  Cycle of Multiplication  with  PVM.--Although  earlier 
studies  (9,  12,  13)  showed  that  hemagglutination  with  PVM  is  attributable "154  CHARACTERISTICS  O1~  THE  MULTIPLICATION  CYCLE  OF  PVM 
to the virus particle per se and demonstrated a fairly close correlation between 
infectivity and hemagglutination titers,  there is no reason to suppose that all 
particles  which  cause  hemagglutination  after  heating  were  infective  before 
such  treatment.  Because  inactivation  of  PVM  by  various  procedures  does 
not  alter  the  hemagglutinating  capacity  (9,  13),  it  is  obvious  that  non- 
infective  viral  particles  in  the  inoculum  or  in  the  mouse  lung  cannot  be 
distinguished from infective particles  by means of the  in  vitro technique.  To 
~haracterize  the  quantitative  and  temporal  features  o'f  a  single  cycle  of 
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Fro. 2. Discrete cycles of multiplication of PVM in the mouse lung as shown by both i, 
~i~o and in ~itro measurements of viral concentration.  The experimental points represent  the 
geometric mean  values  of either  infectivity  or hemagglutination  titrations  in  two experi- 
ments. In each experiment a group of 6 mice inoculated with  I0  *.s M.S.50 doses of virus was 
used at each time interval.  Hemagglutinafion  titers  represent  the final dilution of the sus- 
pension. Infectivity titers represent the final dilution of the ground lung. The titers shown at 
zero time were computed from the corresponding titers of the inoculum. 
multiplication  as precisely  as possible,  it  appeared  essential  to  utilize  both 
infectivity  and hemagglutlnation  titrations  simultaneously. 
The experimental procedure was identical with that described above except that a some- 
what iarger inoculum, i.e., 10  s's M.S.50 doses of virus, was employed. When lung suspensions 
were prepared  at various  intervals  after  inoculation,  each was divided  into two aliquots: 
one was employed for hemagglutination titrations;  the other was used for infectivity titrations. 
The  results obtained in two separate experiments are  presented  graphically 
in  Fig.  2.  Each  end point  shown  represents  the  geometric mean  of the  two 
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titrations.  Although  the  infectivity and hemagglutination  titers  of  the  in- 
oculum corresponded as  closely as was  to  be  expected  from earlier  studies 
(9,  13), there was a striking discrepancy in the amount of virus demonstrabie 
in the lung by the in vivo and in vitro techniques within 6 minutes  after in- 
oculation. Because infectivity of PVM is a labile property which can be altered 
by any of a  number of indeterminate factors, it would  be  hazardous to rely 
solely on  computations based  on differences in  infectivity titrations.  How- 
ever,  on the basis  of hemagglutination titrations, which  depend upon a  re- 
markably stable property of the agent, it appears  that  on the average only 
about 10 per cent of the virus in the inoculum reaches the lung. The differ- 
ence in results obtained by infectivity and hemagglutination titrations at 6 
minutes became even more marked until the 12th hour when, despite a hemag- 
glutination titer of 1:32, almost no infective virus was found. Because PVM 
is released from combination with lung tissue or RBC (9,  10, 13) by the pro- 
cedure utilized to demonstrate hemagglutination, it cannot be assumed that 
the progressive decrease in hemagglutination titer is attributable to adsorp- 
tion of the virus. On the other hand, adsorption by susceptible cells may con- 
tribute somewhat to the striking decrease in infective virus even though there 
is evidence that PVM in combination with lung tissue components retains in- 
fectivity  (9,  13,  14).  Another  possibility must  be  considered; perhaps  the 
infecting viral  particles  become  non-demonstrable  once  they have  invaded 
susceptible cells, as appears to be the case with bacterial viruses (15) and in- 
fluenza viruses (16).  An additional factor may be elimination of much of the 
virus, possibly by enzyme action. 
The 100-fold increase in infectivity titer between 12 and 18 hours provides 
clear evidence that infective virus was formed during this period. In line with 
current concepts it may be assumed that the increase is  attributable  to  new 
viral particles which develop during the latent period.  Because of  the  rela- 
tively large amount of non-infective but hemagglutinating virus remaining at 
12 hours, it is not surprising that the small increment of infective virus was 
not reflected in any significant increase in hemagglutination titer at 18 hours. 
From 24  to 33 hours there was no clear evidence of a  significant change in 
viral concentration; at 48 hours an additional increase in titer was demonstrable 
by either technique. During the period from 24 to 48 hours the correspondence 
between infectivity and hemagglutination titers Was reasonably close. 
These results indicate that with PVM the latent period is at least  12 hours 
in length and that a  single cycle of multiplication occupies 24  to 30 hours. 
The yield of virus during a  single cycle appears to be 16-fold on the basis of 
the amount demonstrable 6 minutes after inoculation. To compute the yield 
from the least amount demonstrable during the latent period, i.e., at 12 hours, 
appears unjustified because this value probably is influenced by one or more 
of the indeterminate factors discussed above. During the 48-hour period the 156  CHARACTERISTICS  OF  THE  MULTIPLICATION CYCLE OF  PV~ 
increment per day appears to be of the order of ninefold by either infectivity 
or  hemagglutination  titrations.  This  value  is  closely similar  to  that  deter- 
mined for the entire incremental period, i.e., 7.9-fold per day, in the preceding 
paper (6). 
Rate of Disappearance of PVM after Inoculation.--It  is evident from the re- 
suits shown  in  Figs 1  and  2,  that  the amount  of PVM  demonstrable  in the 
mouse  lung  decreases  progressively during  the  first  few  hours  following  in- 
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Fro. 3.  Rate of disappearance of active and heat-inactivated PVM from the mouse lung. 
Fr.B =  0.1 rag. of capsular polysaccharide  of Friedlinder bacillus,  type B. PVM heated = 
56  ° C. 30 minutes. 
terial cells (15), has been observed under analogous conditions. Although various 
hypotheses have been proposed regarding this phenomenon, it requires further 
study  in order to  elucidate the factors responsible. 
Two  experimental procedures  were  employed: In one,  mice were given intranasally 0.1 
mg. of capsular polysaccharide  of Friedlinder bacillus,  type B  (Fr.B)  1 so as to render them 
incapable of supporting multiplication of PVM (17). One day later the treated animals were 
given  10  s's M.S.50  doses of active virus intranasally and the rate of disappearance of the 
virus was  followed with  hemagglutination  titrations.  Control  animals were  given  saline 
intranasally one day before active PVM. In the other, PVM was inactivated by heat sufficient 
to destroy infectivity, i.e., 56  ° C. for 30 minutes (9), and the rate of disappearance of the non- 
t The polysaccharide  was  kindly provided  by Dr.  Walther F.  Goebel,  the Rockefeller 
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infective virus from the mouse lung was followed with hemagglufination fitrations at intervals 
after intranasal instillation. In addition, mice treated with Fr.B were given heat-inactivated 
virus as above. 
The  results of four experiments are summarized in Fig.  3;  each end point 
represents  the geometric mean of the hemagglutination titers of lungs from 
groups of mice killed at  the  indicated time after inoculation. Following in- 
oculation  of  active  PVM  in  mice  treated  with  FriedlRnder polysaccharide 
(Fr.  B.),  viral  concentration  in  the  lung  decreased  logarithmically and  no 
hemagglutination was demonstrable at 24 hours. By this time control animals 
had developed an eightfold or greater increase in viral titer. The rate of de- 
crease in viral concentration was of the order of 32-fold per day which is similar 
to that shown in Figs. 1 and 2, indicating that the presence of Fr. B. did not 
alter the process significantly although it effectively inhibited multiplication 
of the agent. 
Heat-inactivated virus also decreased in concentration after intranasal in- 
stillation but at a considerably slower rate than active virus in Fr. B.-treated 
animals. It should be noted that pretreatment with the polysaccharide had 
no effect upon the rate at which heat-inactivated virus disappeared from the 
mouse lung. Thus, it appears  that inactivated virus  is less susceptible  than 
active virus to  the factors which cause PVM  to disappear after inoculation. 
Whether non-infective viral particles in an inoculum are affected differently 
than infective particles cannot be determined until separation of the two can 
be accomplished. 
DISCUSSION 
The  hypothesis that  PVM,  like  bacterial  viruses  (1,  2),  influenza  (3,  4), 
and mumps viruses (5), multiplies in discrete cycles, characterized by a latent 
period and an incremental period during which viral concentration increases, 
appears to be supported by the experimental evidence obtained in the present 
study. An important feature with PVM is the large proportion of virus which 
is no longer demonstrable in the mouse lung within a  matter of hours after 
it has reached this organ. This is much more marked when measurements of 
infectivity are made than when the concentration of the agent is determined 
in  vitro.  That this is not entirely the result of adsorption appears clear from 
the facts that: the procedure employed to prepare the agent for measurement 
in  vitro  causes dissociation of virus adsorbed on lung tissue  (9,  10,  18);  the 
remarkable  heat  stability of the hemagglutinating capacity of PVM  makes 
it possible to  treat  infected tissues and determine the amount of the  agent 
in  vitro  after procedures which would entirely eliminate  other  viruses;  the 
mouse lung itself, probably by enzymatic activity, can dissociate active virus 
from  tissue  particles  and  permit  host  cell  infection  to  occur  (14).  Earlier 
studies  (9)  showed  that  in  ground  lung  suspensions  the  hemagglutinating 158  Ct~ARACTERISTIcS  OF  THE  ~M'ULTIPLICATION CYCLE OF  PV~ 
capacity of the virus did not diminish during 24 hours at 37 ° C. Thus, it ap- 
pears that disappearance of the agent does not occur in the absence of intact 
lung cells. Other workers (15,  16) have pointed to the large losses of infective 
virus which follow inoculation of certain agents and have raised the possibility 
that the infecting particle is so altered as to be non-demonstrable by in dvo 
procedures. The data presented above suggest that in the case of PVM much 
of the non-infectious virus may still bring about hemagglutination of mouse 
erythrocytes. On  the  other hand,  the  logarithmic rate  of disappearance  of 
the virus is what would be expected were the effect the results of enzymatic 
inactivation.  It has been  shown previously  (9,  13)  that both  infective and 
heat-inactivated PVM are acted upon by proteolytic enzymes and then be- 
come non-demonstrable.  In addition, evidence for the presence  of such en- 
zymes in the intact mouse lung has been obtained (14).  That enzymatic ac- 
tivity could result in more rapid inactivation of the infective property of the 
virus  than  in  the  capacity  to  cause  hemagglutination seems  probable.  On 
this basis, infection would be initiated 0nly by those viral particles which es- 
caped inactivation. 
Precise determination of the quantitative features of a single cycle of multi- 
plication of PVM is made difficult because of the large amount of virus which 
disappears during the first 12  to 15 hours after inoculation. In addition, the 
relatively large proportion of the  inoculated virus  which, although rendered 
n0n-infective, retains the capacity to cause hemagglutination serves to obscure 
events during this period.  Nonetheless, the evidence permits certain deduc- 
tions  regarding  the  temporal  aspects  of a  single  cycle of multiplication of 
this agent: The latent period appears to be of the order of 15 hours. The in- 
cremental period occupies a  further 10 to  15 hours. The time required for a 
complete cycle lies in the range of 24 to 30 hours. The amount of virus formed 
per cycle appears to be of the order of 16 times that present at the beginning 
of the cycle. 
Evidence  indicative of a  viral concentration plateau  after  the  first cycle 
of  multiplication  was  obtained  in  each  separate  experiment;  the  plateau 
persisted approximately 6 to 8  hours and was followed regularly by a  period 
during which viral  concentration increased a  second  time.  Several steps  of 
this  sort  in  the  multiplication  of  bacteriophage  have  been  demonstrated 
previously  (1,  2).  Evidence favoring a  second step  has  been  obtained  also 
with mumps virus (5). 
The data obtained in this study on PVM indicate that the first demonstrable 
increase in viral concentration, following the latent period, is associated with 
a marked rise in the infectivity titer. This is closely paralleled by an increase 
in hemagglutination titer.  Whether the  two titers begin  to  increase at pre- 
cisely the  same  time  could  not be  determined  because  of  the  considerable 
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during  the  latent  period.  However,  it  seems  doubtful that  any  significant 
quantity of non-infective PVM  was  released  in  advance of infective virus. 
With influenza viruses other workers (19-21)  have obtained results which led 
them to suggest that non-infective viral material may be formed before fully 
infective particles. 
In the preceding paper  (6)  reasons were given for thinking that somewhat 
less than 1 per cent of the infective virus contained in the inoculum is success- 
ful in initiating infection of susceptible cells.  Data confirmatory of this view 
were obtained in the present study. It should be emphasized that this amount 
of failure is in part the result of mechanical factors inherent in the intranasal 
route of inoculation which lead to no more than 10 per cent of the virus reach- 
ing the lung. As is shown both in the preceding paper (6) and that which fol- 
lows (22),  no evidence of similar failure was obtained in multiplication cycles 
after the first. 
SU~KMARY 
A study of the multiplication of PVM in the mouse lung yielded evidence 
in support of the hypothesis that discrete cycles occur. The cycle is charac- 
terized by a latent period of about 15 hours, an incremental period of 10 to 15 
hours and a  total duration of 24 to 30 hours.  The yield of virus per cycle is 
approximately 16-fold. 
A  large proportion,  approximately 90  per  cent, of PVM  is lost on intra- 
nasal inoculation and cannot be recovered from the lung. Of the virus which 
reaches the lung, almost all becomes non-infective within 12 hours even though 
a considerable amount retains the capacity to cause hemagglutination. During 
the incremental period infective virus appears as soon as any increase in hemag- 
glutination is demonstrable. 
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